Weilan Biotech (603739.SH) released results for the first three quarters, with net profit of 62.9 million yuan to mother, an increase of 1.82% over the previous year

Zhitongcaijing · 3d ago

According to Zhitong Finance App News, Weilan Biotech (603739.SH) disclosed its report for the third quarter of 2026. In the first three quarters, the company achieved operating income of 1,097 billion yuan, up 7.97% year on year; net profit to mother of 62.9 million yuan, up 1.82% year on year; after deducting non-net profit of 41.11 million yuan, up 79.25% year on year; basic earnings per share were 0.25 yuan.